Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)

Mohammed Al‐Qahtani(King Khalid University), Daniëlle J. Vugts(Amsterdam University Medical Centers), Robert H. Mach(California University of Pennsylvania), Clemens Decristoforo(Innsbruck Medical University), Xiang‐Guo Li(Turku PET Centre), Peter J. H. Scott(University of Michigan), Giuseppe Carlucci(UCLA Health), Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal), Jan Passchier(Invicro (United Kingdom)), Klaus Kopka(German Cancer Research Center), Oskar Middel(St Olav's University Hospital), Marianne Patt, Philip H. Elsinga(University Medical Center Groningen), Sergio Todde(University of Milano-Bicocca), Martin Béhé(Paul Scherrer Institute), Guy Bormans(KU Leuven), Jun Toyohara(Tokyo Metropolitan Institute of Gerontology), Ana Rey(Universidad de la República de Uruguay), Iván Peñuelas(Clinica Universidad de Navarra)
EJNMMI Radiopharmacy and Chemistry
January 28, 2021
Cited by 1


Related Papers